AROA BIOSURGERY LIMITED — Director's Dealing 2023

Mar 30, 2023

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Aroa Biosurgery Limited ARBN 638 867 473

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	John Diddams
Date of last notice	16 December 2022

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest		Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.		Whitfield Investments Pty Ltd <John FDiddams Family Trust> (Beneficiary)Galdarn Pty Ltd (Beneficiary)
Date of change		31 March 2023
No. of securities held prior to change		IndirectWhitfield Investments Pty Ltd<John F_Diddams Family Trust> _928,675 Fully Paid Ordinary Share20,452 Options exercisable at A$1.07expiring 30 November 2027Galdarn Pty Ltd263,875 Fully Paid Ordinary Shares
Class		Options exercisable at $1.083 expiring 29February 2028
Number acquired		172,620
Number disposed		-

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/Consideration	Nil
Note: If consideration is non-cash, provide details and estimated
valuation
No. of securities held after change	Indirect
	Whitfield Investments Pty Ltd<John F
	_Diddams Family Trust> _
	928,675	Fully Paid Ordinary Share
	20,452	Options exercisable at A$1.07
		expiring 30 November 2027
	172,620	Options exercisable at $1.083
		expiring 29 February 2028
	Galdarn	_Pty Ltd _
	263,875	Fully Paid Ordinary Shares
Nature of change	Issued	on 31 March 2023 pursuant to
Example: on-market trade, off-market trade, exercise of options,issue of securities under dividend reinvestment plan, participation inbuy-back	shareholder approval received at the AnnualGeneral Meeting held on 10 August 2022

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	-
Nature of interest	-
Name of registered holder	-
(if issued securities)
Date of change	-
No. and class of securities to which interest	-
related prior to change
Note: Details are only required for a contract in relation to which the
interest has changed
Interest acquired	-
Interest disposed	-
Value/Consideration	-
Note: If consideration is non-cash, provide details and an estimated
valuation
Interest after change	-

Part 3 –[+] Closed period

Were the interests in the securities or No contracts detailed above traded during a + closed period where prior written clearance was required?

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

If so, was prior written clearance provided toallow the trade to proceed during thisperiod?	N/A
If prior written clearance was provided, onwhat date was this provided?	N/A

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 3